| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033641 |
| Receipt No. | R000038358 |
| Official scientific title of the study | A prospective cohort study of effect on sexuality after treatment among cervical cancer patients (JGOG9004) |
| Date of disclosure of the study information | 2018/08/06 |
| Last modified on | 2019/01/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | A prospective cohort study of effect on sexuality after treatment among cervical cancer patients (JGOG9004) | |
| Title of the study (Brief title) | Sexuality change among cervical cancer patients (JGOG9004) | |
| Region |
|
|
| Condition | |||
| Condition | cervical cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To reveal sexuality change after cancer treatment among Japanese cervical cancer patients using Female Sexual Function Index (FSFI) and Hospital Anxiety and Depression Scale (HADS). |
| Basic objectives2 | Others |
| Basic objectives -Others | To clarify the factors related to sexual dysfunction after cancer treatment in Japanese primary cervical cancer patients. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | FSFI
-change from baseline to 12 months after treatment start |
| Key secondary outcomes | sexual activity
HADS -change from baseline to 12 months after treatment start |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) Patient who has pathologically diagnosed cervical cancer.
2) Patient who was diagnosed of cervical cancer within 3 months before registration. 3) FIGO IA - IIIB(FIGO 2008). 4) ECOG PS 0 - 1. 5) Aged 20 years and over and under 70 6) A patient who is a married woman. 7) A patient planning curative surgery or radical radiation therapy (including chemoradiotherapy) within 2 months after enrollment. 8) A patient whose consent was obtained in writing. |
|||
| Key exclusion criteria | 1) Patients who have judged that research researcher or research sharing doctor is inappropriate for participation in this study.
2) Patients planning preoperative chemotherapy. 3) Pregnant patient. 4) Patients with mental disease. |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Hitomi Sakai |
| Organization | Kindai University Faculty of Medicine |
| Division name | Department of Medical Oncology |
| Address | 377-2, Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan |
| TEL | 0723660221 |
| sakai_h@med.kindai.ac.jp | |
| Public contact | |
| Name of contact person | Hitomi Sakai |
| Organization | Kindai University Faculty of Medicine |
| Division name | Department of Medical Oncology |
| Address | 377-2, Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan |
| TEL | 0723660221 |
| Homepage URL | http://www.jgog.gr.jp/ |
| sakai_h@med.kindai.ac.jp | |
| Sponsor | |
| Institute | Japanese Gynecologic Oncology Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese Gynecologic Oncology Group |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 婦人科悪性腫瘍研究機構 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | N/A |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038358 |